CHRDL2 Protein, Mouse (HEK293, His)

Customer Review

Based on 1 Customer Validation

CHRDL2 protein is related to tumor angiogenesis and may negatively regulate BMP activity by hindering the interaction between BMP and receptors. It significantly affects cartilage formation and regeneration, suggesting a role in regulating matrix accumulation of immature mesenchymal cells. CHRDL2 Protein, Mouse (HEK293, His) is the recombinant mouse-derived CHRDL2 protein, expressed by HEK293 , with C-6*His labeled tag.

For research use only. We do not sell to patients.
  • Species: Mouse
  • Source: HEK293
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

CHRDL2 protein is related to tumor angiogenesis and may negatively regulate BMP activity by hindering the interaction between BMP and receptors. It significantly affects cartilage formation and regeneration, suggesting a role in regulating matrix accumulation of immature mesenchymal cells. CHRDL2 Protein, Mouse (HEK293, His) is the recombinant mouse-derived CHRDL2 protein, expressed by HEK293 , with C-6*His labeled tag.

Background

CHRDL2 Protein is implicated in tumor angiogenesis, potentially acting as a negative regulator of BMPs activity by obstructing their interaction with respective receptors. It exhibits a significant impact on cartilage formation and regeneration, suggesting a role in modulating the rate of matrix accumulation from immature mesenchymal cells. Furthermore, CHRDL2 may play a regulatory role during myoblast and osteoblast differentiation and maturation processes. Notably, CHRDL2 interacts with various members of the BMP family, including GDF5, INHBA, BMP2, BMP4, BMP5, BMP6, and BMP7, indicating its involvement in diverse cellular and developmental pathways.

Verified Bioactivity

Measured by its ability to inhibit BMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The IC50for this effect is 51.19 ng/mL in the presence of 150 ng/mL of rhBMP-4.

MCE Validation Data

  • Purity - SDS-PAGE

    Purity - SDS-PAGE

    ≥ 95%, as determined by reducing SDS-PAGE.

  • Bioactivity - Cell-Based Assay

    Bioactivity - Cell-Based Assay

    Measured by its ability to inhibit BMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The IC50for this effect is 51.19 ng/mL in the presence of 150 ng/mL of rhBMP-4.

Technical Parameters

  • Species Mouse
  • Source HEK293
  • Tag C-6*His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • CHRDL2 (Q24-L426)
      Accession # Q8VEA6-1
    • 6*His
    • C-term
  • Protein Length

    Full Length of Isoform-1

  • Synonyms

    CHRDL2; Chordin-Related Protein 2; Chordin Like 2; Chordin-Like Protein 2; BNF1; Chordin-Related Protein 2 Variant III; CHL2; BNF-1; Breast Tumor Novel Factor 1

  • AA Sequence

    QARSRSGKVCLFGEKIYTPGQSWHPYLEPQGTIYCVRCTCSENGHVNCYRLRCPPLHCSQPVMEPQQCCPRCVDPHVPSGLRVPLKSCQLNETTYQHGEIFSAQELFPARLSNQCVLCSCIEGHTYCGLMTCPEPSCPTTLPLPDSCCQTCKDRTTESSTEENLTQLQHGERHSQDPCSERRGPSTPAPTSLSSPLGFIPRHFQSVGMGSTTIKIILKEKHKKACTHNGKTYSHGEVWHPTVLSFGPMPCILCTCIDGYQDCHRVTCPTQYPCSQPKKVAGKCCKICPEDEAEDDHSEVISTRCPKVPGQFHVYTLASPSPDSLHRFVLEHEASDQVEMYIWKLVKGIYHLVQIKRVRKQDFQKEAQNFRLLTGTHEGYWTVFLAQTPELKVTASPDKVTKTL

  • Molecular Weight

    Approximately 60-75 kDa, based on SDS-PAGE under reducing conditions.

  • Glycosylation

    Yes

  • Purity

    ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Lyophilized powder.

Formulation

1.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.
2.Lyophilized from a 0.22 μm filtered solution of 20 mM PB, 150 mM NaCl, pH 7.4.
Please refer to the lot-specific COA for specific buffer information.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00